Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MindBio Therapeutics Corp C.MBIO

Healthcare Biotechnology
MindBio Therapeutics Corp. is a biotech/biopharma company. It creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. It is focused on microdosing of psychedelic medicines and is advancing its... see more

CSE:MBIO - Post Discussion

MindBio Therapeutics Corp > Letter to Shareholders Discussing the Company’s Growth Plans
View:
Post by bveilleu on May 16, 2023 5:40am

Letter to Shareholders Discussing the Company’s Growth Plans

MindBio Therapeutics Chief Executive Officer Issues Letter to Shareholders Discussing the Company’s Growth Plans

MindBio Therapeutics Chief Executive Officer Issues Letter to Shareholders Discussing the Company’s Growth Plans (ceo.ca)
Comment by MarketMaestro on May 16, 2023 11:21am
That letter added some weight. Although their proprietary delivery system and route to profitability with an off-patent drug are still a little unclear, the repository of data they will compile appears to be groundbreaking in the industry and should generate a lot of interest.
MindBio Therapeutics Corp